Kikuchi-Fujimoto Disease as the Initial Presentation of Dermatomyositis

Key Points

• Optimal outcomes require early recognition of underlying autoimmune diseases like dermatomyositis.
• Immunosuppressive therapy is critical for patients with atypical refractory Kikuchi-Fujimoto disease.
• Consideration of autoimmune diseases can lead to better management and improved patient care.
• This case emphasizes the significance of accurate diagnosis and prompt intervention strategies.